These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9465083)

  • 21. Antigen presentation in the autoimmune diabetes of the NOD mouse.
    Unanue ER
    Annu Rev Immunol; 2014; 32():579-608. PubMed ID: 24499272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS; Cetkovic-Cvrlje M; Ramiya VK; Atkinson MA; Maclaren NK; Singh B; Elliott JF; Serreze DV; Leiter EH
    J Immunol; 1996 Aug; 157(3):1279-87. PubMed ID: 8757636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface.
    Bhatnagar A; Milburn PJ; Lobigs M; Blanden RV; Gautam AM
    J Immunol; 2001 Apr; 166(7):4490-7. PubMed ID: 11254705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
    Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
    J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
    Koarada S; Wu Y; Ridgway WM
    J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Understanding the interaction of genetics and cellular responses in nonobese diabetic mice.
    Ridgway WM; Fathman CG
    Curr Dir Autoimmun; 2001; 4():218-38. PubMed ID: 11569404
    [No Abstract]   [Full Text] [Related]  

  • 27. The inability of the nonobese diabetic class II molecule to form stable peptide complexes does not reflect a failure to interact productively with DM.
    Peterson M; Sant AJ
    J Immunol; 1998 Sep; 161(6):2961-7. PubMed ID: 9743359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
    Quartey-Papafio R; Lund T; Chandler P; Picard J; Ozegbe P; Day S; Hutchings PR; O'Reilly L; Kioussis D; Simpson E
    J Immunol; 1995 May; 154(10):5567-75. PubMed ID: 7730655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MHC class II molecule I-Ag7 exists in alternate conformations that are peptide dependent.
    Arneson LS; Peterson M; Sant AJ
    J Immunol; 2000 Aug; 165(4):2059-67. PubMed ID: 10925290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7.
    Reizis B; Eisenstein M; Bocková J; Könen-Waisman S; Mor F; Elias D; Cohen IR
    Int Immunol; 1997 Jan; 9(1):43-51. PubMed ID: 9043946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elimination of self-peptide major histocompatibility complex class I reactivity in NOD and beta 2-microglobulin-negative mice.
    Huang R; Guo J; Li X; Faustman DL
    Diabetes; 1995 Sep; 44(9):1114-20. PubMed ID: 7657037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A conformationally-constrained MHC class II I-Ag7-derived peptide protects NOD mice from the development of diabetes.
    Dunsavage MB; O'Leary CJ; Baumgart TD; Solvason N; Howard M; Lafferty K; Deshpande S; Reich EP
    J Autoimmun; 1999 Jun; 12(4):233-42. PubMed ID: 10330294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunization with an insulin peptide-MHC complex to prevent type 1 diabetes of NOD mice.
    Zhang L; Stadinski BD; Michels A; Kappler JW; Eisenbarth GS
    Diabetes Metab Res Rev; 2011 Nov; 27(8):784-9. PubMed ID: 22069260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NOD B-cells are insufficient to incite T-cell-mediated anti-islet autoimmunity.
    Moore DJ; Noorchashm H; Lin TH; Greeley SA; Naji A
    Diabetes; 2005 Jul; 54(7):2019-25. PubMed ID: 15983202
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice.
    Serreze DV; Gaskins HR; Leiter EH
    J Immunol; 1993 Mar; 150(6):2534-43. PubMed ID: 8450229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes.
    Trembleau S; Penna G; Gregori S; Magistrelli G; Isacchi A; Adorini L
    J Immunol; 2000 Dec; 165(12):6748-55. PubMed ID: 11120794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC-mismatched chimerism is required for induction of transplantation tolerance in autoimmune nonobese diabetic recipients.
    Wang M; Racine J; Zhang M; Wu T; Deng R; Johnston H; Shen C; Siswanto K; Zeng D
    J Immunol; 2014 Aug; 193(4):2005-15. PubMed ID: 25000982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?
    Suri A; Levisetti MG; Unanue ER
    Curr Opin Immunol; 2008 Feb; 20(1):105-10. PubMed ID: 18082388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.